Invesco
AHCO icon

Invesco’s AdaptHealth AHCO Stock Holding History

Invesco’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.4M Sell
1,571,240
-68,642
-4% -$766K ﹤0.01% 1624
2026
Q1 		$19.5M Sell
1,639,882
-37,378
-2% -$382K ﹤0.01% 1471
2025
Q4 		$16.7M Sell
1,677,260
-145,629
-8% -$1.39M ﹤0.01% 1562
2025
Q3 		$16.3M Sell
1,822,889
-83,185
-4% -$770K ﹤0.01% 1558
2025
Q2 		$18M Buy
1,906,074
+634,973
+50% +$5.6M ﹤0.01% 1489
2025
Q1 		$13.8M Sell
1,271,101
-162,071
-11% -$1.63M ﹤0.01% 1615
2024
Q4 		$13.6M Buy
1,433,172
+155,838
+12% +$1.58M ﹤0.01% 1669
2024
Q3 		$14.3M Sell
1,277,334
-20,852
-2% -$222K ﹤0.01% 1646
2024
Q2 		$13M Buy
1,298,186
+50,324
+4% +$511K ﹤0.01% 1655
2024
Q1 		$14.4M Buy
1,247,862
+250,710
+25% +$2.13M ﹤0.01% 1619
2023
Q4 		$7.27M Sell
997,152
-217,047
-18% -$1.71M ﹤0.01% 2027
2023
Q3 		$11M Sell
1,214,199
-26,943
-2% -$323K ﹤0.01% 1688
2023
Q2 		$15.1M Buy
1,241,142
+430,802
+53% +$4.8M ﹤0.01% 1526
2023
Q1 		$10.1M Buy
810,340
+121,567
+18% +$2.24M ﹤0.01% 1787
2022
Q4 		$13.2M Buy
688,773
+151,846
+28% +$3.21M ﹤0.01% 1641
2022
Q3 		$10.1M Buy
536,927
+453,523
+544% +$9.32M ﹤0.01% 1785
2022
Q2 		$1.5M Buy
83,404
+12,372
+17% +$201K ﹤0.01% 2821
2022
Q1 		$1.14M Buy
71,032
+43,418
+157% +$781K ﹤0.01% 3018
2021
Q4 		$675K Sell
27,614
-297
-1% -$6.97K ﹤0.01% 3257
2021
Q3 		$650K Buy
27,911
+1,648
+6% +$39.9K ﹤0.01% 3307
2021
Q2 		$720K Buy
26,263
+11,285
+75% +$322K ﹤0.01% 3269
2021
Q1 		$550K Sell
14,978
-170,916
-92% -$6.04M ﹤0.01% 3307
2020
Q4 		$6.98M Buy
185,894
+144,544
+350% +$4.47M ﹤0.01% 2004
2020
Q3 		$902K Buy
41,350
+9,569
+30% +$201K ﹤0.01% 2868
2020
Q2 		$512K Buy
+31,781
New +$531K ﹤0.01% 3117

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco's AHCO Position: Q2 2026 in Review

Invesco reduced its AdaptHealth (AHCO) stake by 4.2% in Q2 2026, selling an estimated $766K and leaving 1,571,240 shares worth $16.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1624.

Invesco first reported a position in AHCO in Q2 2020 and has held it in 25 quarters since. The position peaked at $19.5M in Q1 2026. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Invesco held 1,571,240 shares of AdaptHealth worth $16.4M as of Q2 2026.
  • Invesco sold 68,642 AdaptHealth shares in Q2 2026, an estimated $766K.
  • AdaptHealth made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #1624 holding.
  • Invesco first reported a position in AdaptHealth in Q2 2020 and has held it in 25 quarters since.
  • Invesco's AdaptHealth position peaked at $19.5M in Q1 2026.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.